Showing results (1891-1900 of 2,234) with videos related to

Sort By:
Pageof 224
EFSA Journal. European Food Safety Authority|September 15, 2021
Modification of the existing maximum residue levels for acetamiprid in various crops, Giulia Bellisai, Giovanni Bernasconi, et al.
EFSA Journal. European Food Safety Authority|September 6, 2021
Review of the existing maximum residue levels for cyflumetofen according to Article 12 of Regulation (EC) No 396/2005, Giulia Bellisai, Giovanni Bernasconi, et al.
EFSA Journal. European Food Safety Authority|September 6, 2021
Review of the existing maximum residue levels for penthiopyrad according to Article 12 of Regulation (EC) No 396/2005, Giulia Bellisai, Giovanni Bernasconi, et al.
EFSA Journal. European Food Safety Authority|August 2, 2021
Modification of the existing maximum residue levels for benzovindiflupyr in leeks and spring onions/green onions/Welsh onions, Giulia Bellisai, Giovanni Bernasconi, et al.
Cancer Research|December 17, 2021
An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic ProgressionManuel C Scheidmann, Francesc Castro-Giner, Karin Strittmatter, et al.
EFSA Journal. European Food Safety Authority|October 1, 2021
Setting of import tolerances for flutianil in various crops, Giulia Bellisai, Giovanni Bernasconi, et al.
Clinical Drug Investigation|January 10, 2019
Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and PrognosisLuna Carrillo-Aleman, Francisco Marín, José M Rivera-Caravaca, et al.
EFSA Journal. European Food Safety Authority|July 14, 2025
Peer review of the pesticide risk assessment for the active substance pendimethalin in light of confirmatory data submitted, Fernando Álvarez, Maria Arena, et al.
EFSA Journal. European Food Safety Authority|July 14, 2021
Modification of the existing maximum residue levels for acrinathrin in peaches and sweet peppers, Giulia Bellisai, Giovanni Bernasconi, et al.
Epilepsy Research|June 9, 2014
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective studyV Villanueva, J M Serratosa, E Guillamón, et al.
Pageof 224